by Team Small News | Nov 16, 2025 | Mankind, Pharma
Mankind Pharma, a leading Indian pharmaceutical company, has been slapped with a Goods and Services Tax (GST) penalty of INR 83 lakh (approximately USD 110,000) by the GST authorities. The penalty was imposed due to alleged irregularities in the company’s GST...
by Team Small News | Nov 16, 2025 | Divi's Laboratories
The US Food and Drug Administration (USFDA) recently conducted an inspection of Unit 1 of Divi’s Laboratories Limited, a leading pharmaceutical company based in India. The inspection was a routine evaluation of the company’s compliance with current Good... by Team Small News | Nov 15, 2025 | Natco, Pharma
Natco Pharma, a leading Indian pharmaceutical company, has reported a decline in its net profit for the second quarter (Q2) of the current financial year. The company’s net profit stood at Rs 517.9 crore, which represents a decline of 23.44% compared to the same... by Team Small News | Nov 15, 2025 | Lupin, Pharma
Lupin Limited, a global pharmaceutical company, has achieved a significant milestone by securing an S&P Global ESG Score of 91 for 2025. This score places the company among a select group of pharmaceutical organizations that have crossed the 90-point threshold,... by Team Small News | Nov 12, 2025 | Aurobindo Pharma, Pharma
Motilal Oswal has recommended a “buy” rating for Aurobindo Pharma, with a target price of Rs 1350. The brokerage firm is optimistic about the company’s future prospects, driven by its strong product pipeline, increasing presence in the US market, and...